Globus Medical GMED EPS (Diluted)
Discontinued — last reported Q1 '26
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Globus Medical in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The official record: Globus Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Globus Medical's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Globus Medical's EPS (diluted)?
- Globus Medical (GMED) reported EPS (diluted) of $0.90 in Q1 2026.
- How has Globus Medical's EPS (diluted) changed year-over-year?
- Globus Medical's EPS (diluted) increased by 66.7% year-over-year, from $0.54 to $0.90.
- What is the long-term trend for Globus Medical's EPS (diluted)?
- Over 4 years (2021 to 2025), Globus Medical's EPS (diluted) has grown at a 28.8% compound annual growth rate (CAGR), from $1.43 to $3.93.
- What does EPS (diluted) mean?
- The amount of profit attributed to each share of common stock, assuming all potential shares are issued.
- How do you interpret EPS (diluted)?
- Higher diluted EPS indicates strong profitability even after accounting for potential share dilution.
- How does EPS (diluted) compare across companies?
- Standardized metric for comparing per-share earnings, accounting for potential dilution across different capital structures.